Vir Biotechnology, Inc. (VIR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Vir Biotechnology, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.91x | -1.92x | -2.19x | 6.51x | 10.29x | -10.68x |
| P/B Ratio | 1.09x | 0.87x | 0.85x | 1.62x | 3.80x | 4.45x |
| P/S Ratio | 12.18x | 13.48x | 15.66x | 2.08x | 4.96x | 47.45x |
| Profitability | ||||||
| Gross Margin | 82.9% | -545.0% | -564.7% | 61.6% | 53.1% | 100.0% |
| Operating Margin | -682.7% | -791.3% | -794.0% | 51.6% | 38.4% | -441.6% |
| Net Margin | -638.9% | -703.4% | -713.7% | 31.9% | 48.3% | -444.1% |
| EBITDA Margin | -621.5% | -685.8% | -744.5% | 52.0% | 38.9% | -433.5% |
| Liquidity | ||||||
| Current Ratio | 5.54x | 8.71x | 9.05x | 4.93x | 4.58x | 7.80x |
| Quick Ratio | 5.54x | 8.71x | 9.05x | 4.93x | 4.58x | 7.80x |
| Leverage | ||||||
| Debt/Equity | 0.24x | 0.09x | 0.08x | 0.06x | 0.10x | 0.10x |
YoY = year-over-year change. Source: FMP..